As the field of medical research forges ahead, certain pioneering companies are facing a formidable hurdle. MMJ BioPharma Labs and MMJ International Holdings, at the forefront of developing cannabis-based pharmaceuticals, find themselves entangled in a problematic scenario with the Drug Enforcement
Cancer treatments have long been a complex array of procedures with varying degrees of success. However, groundbreaking research from the University of Houston, spearheaded by Navin Varadarajan and his team, has shone a light on a new horizon for cancer therapy. They have identified CD8-fit T
Despite tremendous advancements in medical science, drug discovery remains a daunting challenge, particularly when it comes to illnesses involving complex protein interactions. Conventional drug development strategies fall short when faced with the vast network of protein-protein interactions
As we witness a demanding push for the development of innovative asthma treatments, over 80 key companies globally have embarked on an ambitious journey. This initiative aims to create a robust arsenal of more than 90 therapeutic approaches, targeting a condition that continues to affect the
The partnership between Tetra Pharm Technologies and Kvantify signifies a major step forward in the realm of drug discovery, particularly within the arena of the endocannabinoid system (ECS). This alliance is poised to not only speed up the discovery process but also holds the promise of yielding
As the battle against cancer continues, one particular area showing remarkable strides is colorectal cancer research and treatment. With over 195 key players in the industry, a testament to the competitive yet collaborative nature of the field, advancements are moving at an incredible pace. From
